Back to Search
Start Over
Ironwood Pharmaceuticals and Allergan Initiate Patient Dosing in Phase II Clinical Trial of MD-7246 in Patients with Abdominal Pain Associated with IBS-D
- Source :
- Business Wire. June 3, 2019
- Publication Year :
- 2019
-
Abstract
- - Top-line data from Phase II trial expected in second half 2020 - CAMBRIDGE, Mass. -- Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), a GI-focused healthcare company, today announced the initiation of patient [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.587567363